vs
ANGIODYNAMICS INC（ANGO）与READING INTERNATIONAL INC（RDI）财务数据对比。点击上方公司名可切换其他公司
ANGIODYNAMICS INC的季度营收约是READING INTERNATIONAL INC的1.6倍（$79.4M vs $50.3M），READING INTERNATIONAL INC净利率更高（-5.1% vs -8.0%，领先2.9%），ANGIODYNAMICS INC同比增速更快（9.0% vs -14.2%），ANGIODYNAMICS INC自由现金流更多（$4.2M vs $4.1M），过去两年READING INTERNATIONAL INC的营收复合增速更高（5.6% vs 2.8%）
AngioDynamics是一家全球医疗技术企业，专注于研发、生产及销售微创医疗设备，核心产品覆盖血管通路、外科消融、肿瘤治疗等领域，面向北美、欧洲、亚太地区的医院、门诊手术中心及各类医疗机构提供服务。
雷丁公司是总部位于美国费城的铁路企业，1924年起在宾夕法尼亚州东部及周边各州提供客运与货运运输服务，直至1976年被联合铁路公司收购。
ANGO vs RDI — 直观对比
营收规模更大
ANGO
是对方的1.6倍
$50.3M
营收增速更快
ANGO
高出23.2%
-14.2%
净利率更高
RDI
高出2.9%
-8.0%
自由现金流更多
ANGO
多$119.0K
$4.1M
两年增速更快
RDI
近两年复合增速
2.8%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $79.4M | $50.3M |
| 净利润 | $-6.3M | $-2.6M |
| 毛利率 | 56.4% | — |
| 营业利润率 | -7.7% | -1.9% |
| 净利率 | -8.0% | -5.1% |
| 营收同比 | 9.0% | -14.2% |
| 净利润同比 | 40.9% | -14.5% |
| 每股收益（稀释后） | $-0.15 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ANGORDI
| Q4 25 | $79.4M | $50.3M | ||
| Q3 25 | $75.7M | $52.2M | ||
| Q2 25 | $80.2M | $60.4M | ||
| Q1 25 | $72.0M | $40.2M | ||
| Q4 24 | $72.8M | $58.6M | ||
| Q3 24 | $67.5M | $60.1M | ||
| Q2 24 | $71.0M | $46.8M | ||
| Q1 24 | $75.2M | $45.1M |
净利润ANGORDI
| Q4 25 | $-6.3M | $-2.6M | ||
| Q3 25 | $-10.9M | $-4.2M | ||
| Q2 25 | $-6.0M | $-2.7M | ||
| Q1 25 | $-4.4M | $-4.8M | ||
| Q4 24 | $-10.7M | $-2.2M | ||
| Q3 24 | $-12.8M | $-7.0M | ||
| Q2 24 | $-13.4M | $-12.8M | ||
| Q1 24 | $-187.7M | $-13.2M |
毛利率ANGORDI
| Q4 25 | 56.4% | — | ||
| Q3 25 | 55.3% | — | ||
| Q2 25 | 52.7% | — | ||
| Q1 25 | 54.0% | — | ||
| Q4 24 | 54.8% | — | ||
| Q3 24 | 54.4% | — | ||
| Q2 24 | 54.3% | — | ||
| Q1 24 | 47.7% | — |
营业利润率ANGORDI
| Q4 25 | -7.7% | -1.9% | ||
| Q3 25 | -14.1% | -0.6% | ||
| Q2 25 | -7.2% | 4.8% | ||
| Q1 25 | -13.9% | -17.2% | ||
| Q4 24 | -15.2% | 2.6% | ||
| Q3 24 | -19.4% | -0.6% | ||
| Q2 24 | -20.4% | -16.4% | ||
| Q1 24 | -265.9% | -16.7% |
净利率ANGORDI
| Q4 25 | -8.0% | -5.1% | ||
| Q3 25 | -14.4% | -8.0% | ||
| Q2 25 | -7.5% | -4.4% | ||
| Q1 25 | -6.1% | -11.8% | ||
| Q4 24 | -14.7% | -3.8% | ||
| Q3 24 | -19.0% | -11.7% | ||
| Q2 24 | -18.9% | -27.4% | ||
| Q1 24 | -249.7% | -29.4% |
每股收益（稀释后）ANGORDI
| Q4 25 | $-0.15 | $-0.11 | ||
| Q3 25 | $-0.26 | $-0.18 | ||
| Q2 25 | $-0.15 | $-0.12 | ||
| Q1 25 | $-0.11 | $-0.21 | ||
| Q4 24 | $-0.26 | $-0.11 | ||
| Q3 24 | $-0.31 | $-0.31 | ||
| Q2 24 | $-0.35 | $-0.57 | ||
| Q1 24 | $-4.67 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $41.6M | $10.5M |
| 总债务越低越好 | — | $185.1M |
| 股东权益账面价值 | $176.3M | $-18.2M |
| 总资产 | $269.7M | $434.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ANGORDI
| Q4 25 | $41.6M | $10.5M | ||
| Q3 25 | $38.8M | $8.1M | ||
| Q2 25 | $55.9M | $9.1M | ||
| Q1 25 | $44.8M | $5.9M | ||
| Q4 24 | $54.1M | $12.4M | ||
| Q3 24 | $55.0M | $10.1M | ||
| Q2 24 | $76.1M | $9.3M | ||
| Q1 24 | $78.5M | $7.5M |
总债务ANGORDI
| Q4 25 | — | $185.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $202.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | $0 | — | ||
| Q1 24 | — | — |
股东权益ANGORDI
| Q4 25 | $176.3M | $-18.2M | ||
| Q3 25 | $178.9M | $-12.1M | ||
| Q2 25 | $183.0M | $-7.7M | ||
| Q1 25 | $185.9M | $-8.1M | ||
| Q4 24 | $186.8M | $-4.4M | ||
| Q3 24 | $196.6M | $1.6M | ||
| Q2 24 | $205.6M | $6.5M | ||
| Q1 24 | $218.7M | $18.0M |
总资产ANGORDI
| Q4 25 | $269.7M | $434.9M | ||
| Q3 25 | $265.6M | $435.2M | ||
| Q2 25 | $280.1M | $438.1M | ||
| Q1 25 | $285.4M | $441.0M | ||
| Q4 24 | $291.6M | $471.0M | ||
| Q3 24 | $293.6M | $495.7M | ||
| Q2 24 | $317.7M | $494.9M | ||
| Q1 24 | $324.8M | $494.9M |
负债/权益比ANGORDI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.7M | $4.3M |
| 自由现金流经营现金流 - 资本支出 | $4.2M | $4.1M |
| 自由现金流率自由现金流/营收 | 5.3% | 8.2% |
| 资本支出强度资本支出/营收 | 0.5% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-9.3M | $-2.9M |
8季度趋势，按日历期对齐
经营现金流ANGORDI
| Q4 25 | $4.7M | $4.3M | ||
| Q3 25 | $-15.9M | $295.0K | ||
| Q2 25 | $18.8M | $1.6M | ||
| Q1 25 | $-13.2M | $-7.7M | ||
| Q4 24 | $2.5M | $8.0M | ||
| Q3 24 | $-18.3M | $1.3M | ||
| Q2 24 | $5.0M | $-10.4M | ||
| Q1 24 | $-12.5M | $-2.8M |
自由现金流ANGORDI
| Q4 25 | $4.2M | $4.1M | ||
| Q3 25 | $-16.6M | $-246.0K | ||
| Q2 25 | $18.0M | $1.2M | ||
| Q1 25 | $-15.0M | $-8.0M | ||
| Q4 24 | $1.7M | $7.0M | ||
| Q3 24 | $-19.3M | $-1.1M | ||
| Q2 24 | $4.4M | $-10.6M | ||
| Q1 24 | $-13.1M | $-4.7M |
自由现金流率ANGORDI
| Q4 25 | 5.3% | 8.2% | ||
| Q3 25 | -22.0% | -0.5% | ||
| Q2 25 | 22.5% | 1.9% | ||
| Q1 25 | -20.8% | -19.8% | ||
| Q4 24 | 2.3% | 12.0% | ||
| Q3 24 | -28.7% | -1.8% | ||
| Q2 24 | 6.2% | -22.7% | ||
| Q1 24 | -17.5% | -10.4% |
资本支出强度ANGORDI
| Q4 25 | 0.5% | 0.3% | ||
| Q3 25 | 1.0% | 1.0% | ||
| Q2 25 | 1.0% | 0.6% | ||
| Q1 25 | 2.5% | 0.6% | ||
| Q4 24 | 1.1% | 1.7% | ||
| Q3 24 | 1.6% | 4.0% | ||
| Q2 24 | 0.8% | 0.5% | ||
| Q1 24 | 0.8% | 4.3% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ANGO
| Med Device | $37.2M | 47% |
| Med Tech | $30.4M | 38% |
| Other | $11.8M | 15% |
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
